comparemela.com

Latest Breaking News On - Recerca biom - Page 1 : comparemela.com

Call for the recruitment of excellent researchers 2024 job with Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré

Call for the recruitment of excellent researchers 2024 job in Lleida (Provincia), Cataluña (ES) with Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré. Apply Today.

Recerca-biom
Rovira-roure
Lleida-fundaci
Scientific-strategy-committee
European-parliament
Institute-recruitment
Board-of-trustees
Catalan-data-protection-authority
Biomedical-research-institute-of-lleida
Biomedical-research-institute
Deputy-director
Scientific-advisory-board

Pharmactive study details benefits of aged black garlic for blood pressure reduction

Results of a new RCT outline the blood pressure balancing effect of Pharmactive Biotech's aged black garlic supplement ABG10+ in patients receiving treatment for hypertension.

Lleida
Comunidad-autonoma-de-cataluna
Spain
Spanish
Recerca-biom
Alberto-espinel
Valero
University-of-lleida
Renal-translational-research-group
Institut-de-recerca-biom
Hospital-universitari-arnau-de-vilanova
Open-innovation-director

CPAP reduces risk for cardiovascular death, hospitalizations in patients with OSA

CPAP reduces risk for cardiovascular death, hospitalizations in patients with OSA
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Milan
Lombardia
Italy
Spain
Lleida
Comunidad-autonoma-de-cataluna
Byisabella-hornick
Recerca-biom
Kristen-dowd
European-respiratory-society-international-congress
European-respiratory-society
European-respiratory-society-international

Treatment for snoring saves lives from heart disease: Study

Treatment for snoring saves lives from heart disease: Study
theprint.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theprint.in Daily Mail and Mail on Sunday newspapers.

Ireland
Spain
Dublin
Cliona-odonnell
Lleida-irblleida
Sophia-schiza
Recerca-biom
University-college-dublin
European-respiratory-society
Vincent-university-hospital
Institut-de-recerca-biom
University-hospital

Cabozantinib Is Safe and Tolerable in Sorafenib-Intolerant HCC

The phase 2 ACTION trial, which evaluated the safety of second-line cabozantinib in patients with hepatocellular carcinoma who were intolerant to first-line sorafenib or who received agents other than sorafenib in the first line, did not meet its safety futility criteria, allowing the trial to continue.

Spain
Barcelona
Comunidad-autonoma-de-cataluna
Marco-sanduzzi-zamparelli
Recerca-biom
International-liver-cancer-association-conference
Liver-cancer-association
Barcelona-clinic-liver-cancer
Safety-monitoring-board
Action-trial
Nct04316182
Patients-with-hepatocellular-carcinoma

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.